Growth Metrics

Edwards Lifesciences (EW) Other Non-Current Assets (2016 - 2026)

Edwards Lifesciences has reported Other Non-Current Assets over the past 17 years, most recently at $784.8 million for Q3 2025.

  • For Q3 2025, Other Non-Current Assets rose 14.82% year-over-year to $784.8 million; the TTM value through Sep 2025 reached $784.8 million, up 14.82%, while the annual FY2024 figure was $10.8 million, 97.67% down from the prior year.
  • Other Non-Current Assets for Q3 2025 was $784.8 million at Edwards Lifesciences, up from $12.8 million in the prior quarter.
  • Over five years, Other Non-Current Assets peaked at $784.8 million in Q3 2025 and troughed at $10.8 million in Q4 2024.
  • A 5-year average of $297.4 million and a median of $293.6 million in 2023 define the central range for Other Non-Current Assets.
  • Biggest five-year swings in Other Non-Current Assets: soared 169.95% in 2022 and later tumbled 98.38% in 2025.
  • Year by year, Other Non-Current Assets stood at $110.8 million in 2021, then surged by 169.95% to $299.1 million in 2022, then surged by 54.86% to $463.2 million in 2023, then crashed by 97.67% to $10.8 million in 2024, then soared by 7166.67% to $784.8 million in 2025.
  • Business Quant data shows Other Non-Current Assets for EW at $784.8 million in Q3 2025, $12.8 million in Q2 2025, and $12.4 million in Q1 2025.